News & Articles

The test uses a convolutional neural network to classify microscopy images of single intact particles of different viruses

In combination with other COVID-19 diagnostic tests, the Elecsys SARS-CoV-2 Antigen test can help in the management of patients for optimal care delivery

Availability of the new IgM blood test on the ARCHITECT and Alinity platforms is part of Abbott's effort to offer tests across the disease progression of COVID-19

The CTS Rotea system aims to help researchers overcome manufacturing hurdles and bring the vast potential of cell therapies to more patients

Find out how experts at the Ellison Institute are harnessing new cell monitoring technology to build cancer cell biobanks and enhance cell line quality control and authentication

Partnership combines Twist’s leadership in DNA synthesis and synthetic biology with Neogene’s expertise in personalized engineered T cell therapies

Summa Equity Fund II acquires a majority stake in Sengenics, a functional proteomics company with a unique technology for production of full-length, correctly folded and functional proteins

Antibodies available are specific for S1, S2 and receptor-binding domain regions of SARS-CoV-2 Spike protein

The CleanPlex ACE2 & TMPRSS2 Panel assesses differences in patients’ genetic susceptibility to COVID-19 infection and to developing severe disease

Find out how to rapidly test for multiple disease-causing microorganisms with syndromic panel-based testing

Join us on Wednesday, October 28, to learn how SpyTag-SpyCatcher technology enables site-directed conjugation and rapid assembly of different antibody format

Combination test for COVID-19, flu and other common respiratory illnesses helps health care professionals prepare for flu season

The addition of COVID-19 antibody tests to the portfolio aims to further support the pandemic response on multiple fronts

Learn how high-throughput, real-time cell analysis can accurately detect and quantify virus-neutralizing antibodies and see how this technology is advancing COVID-19 research

Rentschler Biopharma to provide cGMP manufacturing services for mRNA-based vaccine candidate, developed by BioNTech and Pfizer against SARS-CoV-2

Samples from the lungs of patients show a runaway immune system reaction could be one mechanism behind severe COVID-19 cases

Join us on Monday, October 19, to find out how targeting BCMA and GPRC5D simultaneously could help to prevent tumor cell escape

We speak with Dr. Ed Emmott, founder of The Emmott Lab & COVID-19 Mass Spec Coalition member, about his latest research into the disease